ArticleMedical physics2025
A novel personalized time-varying biomechanical model for estimating lung tumor motion and deformation.
Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- 3D Reactive Oxygen Species Dosimetry in Pleural Photodynamic Therapy: Integration of Macroscopic Kinetic Modeling and Deformable Registration.Antioxidants (Basel, Switzerland) · 2026Article
- Dual-metric Bayesian optimization of B-spline mesh size for 4DCT lung registration.European journal of radiology open · 2025Article
- A novel personalized time-varying biomechanical model for estimating lung tumor motion and deformation.Medical physics · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
Abstract
backgroundAccurate prediction of lung tumor motion and deformation (LTMD) is essential for precise radiotherapy. However, existing models often rely on static, population-based material parameters, overlooking patient-specific and time-varying lung biomechanics. Personalized dynamic models that capture temporal changes in lung elasticity are needed to improve LTMD prediction and guide treatment planning more effectively. PURPOSE: This study aims to develop a patient-specific, time-varying biomechanical model to predict LTMD more accurately.
methodsFour-dimensional computed tomography (4DCT) images from 27 patients, each with 10 breathing phases, were analyzed. A finite element model was developed, modeling lung as a hyper-elastic material and tumor as linear elastic. Lung elasticity parameters, including Young's modulus (E) and Poisson's ratio (v), were optimized for each phase using Efficient Global Optimization algorithm. Four functions were tested to model the variation of E and v across different phases. For each patient, average values of these parameters were computed, and their correlation with 11 clinical features was analyzed. The model's accuracy in predicting LTMD was evaluated using tumor center of mass motion error (ΔTCM) and volumetric Dice similarity coefficient (vDSC). Factors influencing the model's accuracy were investigated. Specifically, lung surface traction vector fields (STVFs) were calculated during the transition from end-expiration to end-inspiration phases, and their relationship with LTMD was also analyzed.
resultsThe first-order Fourier function provided the best fit among four tested functions, with average R-squared values of 0.93 ± 0.03 for E and 0.91 ± 0.03 for v. The average values of E and v were significantly correlated with patient age. The model showed a mean ΔTCM of 1.47 ± 0.68 mm and a mean vDSC of 0.93 ± 0.02. A negative correlation was found between tumor deformation vDSC and ΔTCM (r = -0.55, p < 0.05). Higher STVFs were observed near diaphragm and intercostal muscles, with correlations between STVFs and tumor motion amplitude (r ≥ 0.92, p < 0.05).
conclusionsThese findings offer new insights into developing personalized, time-varying motion management strategies of lung tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.